Bristol-Myers Squibb Company

    BMY ·NYSE ·Pharmaceutical Preparations ·Inc. in DE
    Loading chart...
    Track markets on TradingView

    Loading financial statements...

    Financial statements

    data from SEC XBRL filings. Values are as-reported; restatements supersede originals.

    showing loading…

    Loading holders...

    Held by

    holders ( registered funds via N-PORT, institutional investors via 13F). Showing top by dollar value.

    Holder Type ETF MF Position ($) % of holder Δ % of holder Holder AUM

    Next expected filings

    • ~2026-07-31 10-Q expected by 2026-08-13 (in 91 days)
    • ~2026-10-30 10-Q expected by 2026-11-12 (in 182 days)
    • ~2027-02-10 10-K expected by 2027-03-02 (in 285 days)
    • ~2027-04-30 10-Q expected by 2027-05-13 (in 364 days)

    Predicted from historical filing cadence; not an SEC commitment.

    Recent SEC filings

    • 2026-04-30 8-K Earnings Release; Regulation FD Disclosure; Financial Statements and Exhibits
    • 2026-04-30 10-Q Quarterly Report
    • 2026-02-11 10-K Annual Report
    • 2026-02-05 8-K Earnings Release; Regulation FD Disclosure; Financial Statements and Exhibits
    • 2025-11-18 8-K Other Events; Financial Statements and Exhibits
    • 2025-11-10 8-K Other Events; Financial Statements and Exhibits
    • 2025-11-03 8-K Other Events; Financial Statements and Exhibits
    • 2025-10-30 10-Q Quarterly Report
    • 2025-10-30 8-K Earnings Release; Regulation FD Disclosure; Financial Statements and Exhibits
    • 2025-07-31 10-Q Quarterly Report
    • 2025-07-31 8-K Earnings Release; Regulation FD Disclosure; Financial Statements and Exhibits
    • 2025-07-25 8-K Officer/Director Change; Financial Statements and Exhibits
    • 2025-04-24 10-Q Quarterly Report
    • 2025-04-24 8-K Earnings Release; Regulation FD Disclosure; Financial Statements and Exhibits
    • 2025-02-18 8-K Officer/Director Change